IPSOGEN

Qiagen Gmbh

Application Filed: 2002-02-20
Trademark Application Details
Trademark Logo IPSOGEN

Mark For: IPSOGEN® trademark registration is intended to cover the categories of biological reagents for diagnoses and for identification of biological systems [ ; pharmaceutical products, namely, preparations, chemical preparations and chemico-pharmaceutical preparations for treating illnesses, namely, genetic and infectious illnesses namely, acute leukemia, acute lymphoblastic leukemia, acute myelogenous leukemia, AML, acute monocytic leukemia, AML, acute promyelocytic leukemia, APL, adenocarcinoma, adenocarcinoma lung cancer, adenocystic carcinoma, adenoid cystic breast cancer, adenoid cystic arcinoma, adrenal gland cancer, advanced breast cancer, aggressive breast cancer, ameloblastoma, anal, anus cancer; angiosarcoma, appendix cancer, appendiceal cancer, astrocytoma, arrett's esophagus, bartholin gland cancer, basal cell carcinoma, basal cell skin cancer, B-cell lymphoma, bilateral breast cancer, bile duct cancer, bladder cancer, bladder metastases, bone cancer, bone marrow transplantation, Bowen's disease, bone metastases, borderline ovarian cancer, brain metastases, brain tumor, brainstem glioma, breast cancer, breast reconstruction, bronchial cancer, bronchioalveolar lung cancer, buttock cancer, cancer of unknown primary site, CUPS, cancer prevention, carcinoma of unknown primary, carcinoid, carcinoid syndrome, carcinoid tumor, carcinosarcoma, cavernous sinus cancer, cecum cancer, central nervous system lymphoma, centrocytic lymphoma, cerebral astrocytoma, cervix cancer, cervical cancer, chest tumors, mediastinum tumors, chiasmal glioma, childhood cancers, chondroma, intracranial, chordoma, chondrosarcoma, chorioadenoma destruens, choroids plexus carcinoma, choroidal melanoma, chronic leukemia, chronic lymphocytic leukemia, CLL, chronic myelogenous leukemia, CML, clear cell ovarian cancer, clear cell sarcoma, CNS lymphoma, colon cancer, adenocarcinoma of the colon, adenomatous polyps, polyps, colorectal cancer, craniopharyngioma, cutaneous T-cell lymphoma, DCIS - ductal carcinoma in situ, dermatofibrosarcoma protuberans, desmoidtumor, desmoplastic tumor, diffuse lymphoma, diffuse, large-cell lymphoma, ductal carcinoma in situ, DCIS, duodenalcancer dysgerminoma, early stage prostate cancer, endocrine cancer, endometrial cancer, endometrial stromal sarcoma, ependymoma, esophagus cancer, esophageal cancer, esophagus cancer of the gastroesophageal junction, esthesioneuroblastoma, Ewing's sarcoma, extensive stage small cell lung cancer, extrahepatic bile duct cancer, extraskeletal chondrosarcoma, extraskeletal Ewing's sarcoma, extraskeletal osteosarcoma, eye metastases, eye cancer, fallopian tube cancer, fibrosarcoma, fibrous histiocytoma, follicular lymphoma, follicular, small-cleaved cell lymphoma, gallbladder cancer, gastric cancer, gastrinoma, gastro-esophageal, GE junction, cancer, gastrointestinal lymphoma, GE junction esophageal cancer, germ cell tumor, gestational trophoblastic disease, giant cell bone tumor, glioblastoma, glioma, gliomatosis, granular lymphocytic lymphoma, granulocytic leukemia, granulosa cell ovarian cancer, hairy cell leukemia, head and neck cancer, hemangioendothelioma, hemangiopericytoma, hepatocelluar carcinoma, high-grade lymphoma, high-risk breast cancer, histiocytoma, malignant, Hodgkin's disease, Hodgkin's disease in pregnancy, hormone-refractory prostate cancer, in situ breast cancer, insulinoma, intermediate-grade lymphoma, intraocular melanoma, invasive lobular breast cancer, islet cell pancreatic cancer, Kaposi's sarcoma, kidney cancer, krukenberg tumor, large-cell lung cancer, large-cell lymphoma, large-cell, diffuse lymphoma, larynx cancer, laryngeal cancer, leiomyosarcoma, lentigo maligna, leukemia, linitis plastica, limited stage small cell lung cancer, lip cancer, liposarcoma, liver cancer, recurrent liver cancer, undifferentiated liver cancer, lobular carcinoma in situ, LCIS, lobular hyperplasia low-grade lymphoma, lung cancer, non-small cell lung cancer, epidermoid carcinoma, large cell carcinoma, squamous cell carcinoma, spindal cell variant, pancoast tumors, superior sSulcus tumors, undifferentiated carcinoma, lung metastases, lymph node excision, lymphangitic metastasis, lymph node metastases, lymphoblastic leukemia, lymphoblastic lymphoma, lymphocytic lymphoma, lymphoma, non-Hodgkin's lymphoma, malignant ascites, malignant hemangiopericytoma, malignant fibrous histiocytoma, malignant peripheral nerve sheath tumor, malignant pleural effusion, malignant schwannoma, MALT lymphoma, mantle cell lymphoma, medlastinal tumor, medulloblastoma, melanoma, meningeal cancer, meningeal metastases, meningioma, merkel cell carcinoma, merkel cell skin cancer, mesothelioma, mesenchymal chondrosarcoma, metastatic melanoma, mixed mullerian tumor, mucinous carcinoma, multiple myeloma, muscle-invasive bladder tumor, mycosis fungoides, myelodysplasia, myelodysplastic syndrome, myeloma, Bence-Jones, myeloproliferative disorder, nail/nail bed cancer, nasal cavity cancer, nasopharynx cancer, neck, radical dissection, neoplastic meningitis, nerve sheath tumors, neuroblastoma, neuroendocrine tumor, adenosquamous carcinoma, adenocarcinoma, ocular melanoma, olfactory cancer, oligodendroglioma, optic glioma, oral cancer, orbital lumphoma, orophaiynx cancer, osteogenic sarcoma, osteosarcoma, ovarian cancer, Pagets disease of the breast, pancreatic cancer, recurrent pancreatic cancer, borderline pancreatic tumors, mucinous cystic tumor with dysplasia, intraductal papillary mucinous tumor with dysplasia, pseudopapillary solid tumor, islet cell tumors, gastrinoma, paraganglioma, paranasal sinus cancer, paraneoplastic syndromes, parathyroid cancer, parotid gland cancer, pelvic tumor, penis cancer, periampullary cancer, pericardial effusion, peripheral nerve sheath tumor, peripheral T-cell lymphoma, peritoneal cancer, extraovarian serous carcinoma, extraovarian peritoneal serious papillary carcinoma, serous surface carcinoma of the peritoneum, serous surface papillary carcinoma, papillary serous carcinoma of the peritoneum, multiple focal peritoneal papillary carcinoma, primary peritoneal papillary serous adenocarcinoma, peritoneal carcinomatosis, pheochromocytoma, pinealoma, pineoblastoma, plasmacytoma, pleura cancer, pleura metastases, preleukemia, primary central nervous system lymphoma, primitive neuroctodermal tumor, PNET, plolymphocytic leukemia, promyelocytic leukemia, prophylactic mastectomy, prostate cancer, prostatic intraepithelial neoplasia, PIN, PSA, pseudomyxoma peritonei, rectal cancer, recurrent colon cancer, recurrent colorectal cancer, recurrent lung cancer, recurrent melanoma, recurrent ovarian cancer, recurrent prostate cancer, recurrent rectal cancer, relapsed lymphoma, renal cell carcinoma, renal pelvis cancer, retinoblastoma, rhabdomyosarcoma, Richters syndrome, rising PSA as an indication of recurrent prostate cancer, salivary gland cancer, sarcoma of bone, sarcomatoid carcinoma; sebaceous carcinoma, sezary syndrome, sinus, cavernous, sinus cancer, skin cancer, skin metastases, small cell bladder cancer, small cell lung cancer, small cleaved cell lymphoma, small intestine cancer, soft tissue lymphoma, soft tissue sarcoma, synovial sarcoma, spinal cord cancer, spindle cell thyroid cancer, squamous cell cancer, non-skin, squamous cell lung cancer, squamous cell skin cancer, stem cell transplantation, stomach cancer, superficial bladder cancer, sweat glands cancer, T-cell leukemia, T-cell lymphoma, cutaneous, testicular cancer, testis cancer, thalamu, thalamic, brain tumor, thymoma, thymus gland cancer, thyroid cancer, thyroid lymphoma, tongue cancer, tongue base cancer, transitional cell cancer of renal pelvis, transitional cell cancer of the ureter, unknown primary cancer, ureter cancer, urethra cancer, uterine cancer, uterine sarcoma, vagina cancer, vocal cord cancer, vulva cancer, Waldenstrom's macroglobulinemia, Warthin's tumor, Wilms' tumor, Zollinger-Ellis syndrome ]. [all]

Status

2022-08-01 UTC
LIVE REGISTRATION Issued and Active
The trademark application has been registered with the Office.


Research OneLook Acronym Finder
Serial Number76373789
Registration Number2958962
Mark Literal ElementsIPSOGEN
Mark Drawing Type1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark TypeTRADEMARK
Standard Character ClaimNo
RegisterPRINCIPAL
Affidavit TextSECT 15. SECT 8 (6-YR). PARTIAL SECTION 8(10-YR) 20151215.
Affidavit Text1ST RENEWAL 20151215
Current LocationTMEG LAW OFFICE 105 2015-12-15
Basis44(e)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseNo
Filed ITUYes
44D FiledYes
44E CurrentYes
66A CurrentNo
Current BasisNo
No BasisNo
Cancellation CodeB
Domestic RepresentativeWilliam B. Slate
Attorney NameWilliam B. Slate
Attorney Docket Number02-180T
Law Office AssignedL50
Employee NameCASE, LEIGH CAROLINE

Timeline

1ST RENEWAL 20151215Renewal Date
2002-02-20Application Filed
2005-03-15Published
2005-03-15Published for Opposition
2005-06-07Trademark Registered
2015-06-07Renewal Date
2015-12-15Location: TMEG LAW OFFICE 105
2015-12-15Status: Live/Registered
2015-12-15Status: The registration has been renewed.
2018-07-08Transaction Date

Trademark Parties (Applicants & Owners)

Party: QIAGEN GMBH
AddressQIAGEN STRASSE 1 40724 HILDEN GERMANY
Legal Entity TypeCompany
Legal Entity StateGERMANY
Party: QIAGEN MARSEILLE
AddressLUMINY BIOTECH ENTREPRISES, CASE 923 163, AVENUE DE LUMINY MARSEILLE FR 13288 CED
Legal Entity Type
Legal Entity State FR

*multiple parties listed, check assignment documents for ownership information

Attorney of Record

William B. Slate
BACHMAN & LAPOINTE, PC
STE 1201
900 CHAPEL ST
NEW HAVEN CT 06510

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Biological reagents for diagnoses and for identification of biological systems [ ; pharmaceutical products, namely, preparations, chemical preparations and chemico-pharmaceutical preparations for treating illnesses, namely, genetic and infectious illnesses namely, acute leukemia, acute lymphoblastic leukemia, acute myelogenous leukemia, AML, acute monocytic leukemia, AML, acute promyelocytic leukemia, APL, adenocarcinoma, adenocarcinoma lung cancer, adenocystic carcinoma, adenoid cystic breast cancer, adenoid cystic arcinoma, adrenal gland cancer, advanced breast cancer, aggressive breast cancer, ameloblastoma, anal, anus cancer; angiosarcoma, appendix cancer, appendiceal cancer, astrocytoma, arrett's esophagus, bartholin gland cancer, basal cell carcinoma, basal cell skin cancer, B-cell lymphoma, bilateral breast cancer, bile duct cancer, bladder cancer, bladder metastases, bone cancer, bone marrow transplantation, Bowen's disease, bone metastases, borderline ovarian cancer, brain metastases, brain tumor, brainstem glioma, breast cancer, breast reconstruction, bronchial cancer, bronchioalveolar lung cancer, buttock cancer, cancer of unknown primary site, CUPS, cancer prevention, carcinoma of unknown primary, carcinoid, carcinoid syndrome, carcinoid tumor, carcinosarcoma, cavernous sinus cancer, cecum cancer, central nervous system lymphoma, centrocytic lymphoma, cerebral astrocytoma, cervix cancer, cervical cancer, chest tumors, mediastinum tumors, chiasmal glioma, childhood cancers, chondroma, intracranial, chordoma, chondrosarcoma, chorioadenoma destruens, choroids plexus carcinoma, choroidal melanoma, chronic leukemia, chronic lymphocytic leukemia, CLL, chronic myelogenous leukemia, CML, clear cell ovarian cancer, clear cell sarcoma, CNS lymphoma, colon cancer, adenocarcinoma of the colon, adenomatous polyps, polyps, colorectal cancer, craniopharyngioma, cutaneous T-cell lymphoma, DCIS - ductal carcinoma in situ, dermatofibrosarcoma protuberans, desmoidtumor, desmoplastic tumor, diffuse lymphoma, diffuse, large-cell lymphoma, ductal carcinoma in situ, DCIS, duodenalcancer dysgerminoma, early stage prostate cancer, endocrine cancer, endometrial cancer, endometrial stromal sarcoma, ependymoma, esophagus cancer, esophageal cancer, esophagus cancer of the gastroesophageal junction, esthesioneuroblastoma, Ewing's sarcoma, extensive stage small cell lung cancer, extrahepatic bile duct cancer, extraskeletal chondrosarcoma, extraskeletal Ewing's sarcoma, extraskeletal osteosarcoma, eye metastases, eye cancer, fallopian tube cancer, fibrosarcoma, fibrous histiocytoma, follicular lymphoma, follicular, small-cleaved cell lymphoma, gallbladder cancer, gastric cancer, gastrinoma, gastro-esophageal, GE junction, cancer, gastrointestinal lymphoma, GE junction esophageal cancer, germ cell tumor, gestational trophoblastic disease, giant cell bone tumor, glioblastoma, glioma, gliomatosis, granular lymphocytic lymphoma, granulocytic leukemia, granulosa cell ovarian cancer, hairy cell leukemia, head and neck cancer, hemangioendothelioma, hemangiopericytoma, hepatocelluar carcinoma, high-grade lymphoma, high-risk breast cancer, histiocytoma, malignant, Hodgkin's disease, Hodgkin's disease in pregnancy, hormone-refractory prostate cancer, in situ breast cancer, insulinoma, intermediate-grade lymphoma, intraocular melanoma, invasive lobular breast cancer, islet cell pancreatic cancer, Kaposi's sarcoma, kidney cancer, krukenberg tumor, large-cell lung cancer, large-cell lymphoma, large-cell, diffuse lymphoma, larynx cancer, laryngeal cancer, leiomyosarcoma, lentigo maligna, leukemia, linitis plastica, limited stage small cell lung cancer, lip cancer, liposarcoma, liver cancer, recurrent liver cancer, undifferentiated liver cancer, lobular carcinoma in situ, LCIS, lobular hyperplasia low-grade lymphoma, lung cancer, non-small cell lung cancer, epidermoid carcinoma, large cell carcinoma, squamous cell carcinoma, spindal cell variant, pancoast tumors, superior sSulcus tumors, undifferentiated carcinoma, lung metastases, lymph node excision, lymphangitic metastasis, lymph node metastases, lymphoblastic leukemia, lymphoblastic lymphoma, lymphocytic lymphoma, lymphoma, non-Hodgkin's lymphoma, malignant ascites, malignant hemangiopericytoma, malignant fibrous histiocytoma, malignant peripheral nerve sheath tumor, malignant pleural effusion, malignant schwannoma, MALT lymphoma, mantle cell lymphoma, medlastinal tumor, medulloblastoma, melanoma, meningeal cancer, meningeal metastases, meningioma, merkel cell carcinoma, merkel cell skin cancer, mesothelioma, mesenchymal chondrosarcoma, metastatic melanoma, mixed mullerian tumor, mucinous carcinoma, multiple myeloma, muscle-invasive bladder tumor, mycosis fungoides, myelodysplasia, myelodysplastic syndrome, myeloma, Bence-Jones, myeloproliferative disorder, nail/nail bed cancer, nasal cavity cancer, nasopharynx cancer, neck, radical dissection, neoplastic meningitis, nerve sheath tumors, neuroblastoma, neuroendocrine tumor, adenosquamous carcinoma, adenocarcinoma, ocular melanoma, olfactory cancer, oligodendroglioma, optic glioma, oral cancer, orbital lumphoma, orophaiynx cancer, osteogenic sarcoma, osteosarcoma, ovarian cancer, Pagets disease of the breast, pancreatic cancer, recurrent pancreatic cancer, borderline pancreatic tumors, mucinous cystic tumor with dysplasia, intraductal papillary mucinous tumor with dysplasia, pseudopapillary solid tumor, islet cell tumors, gastrinoma, paraganglioma, paranasal sinus cancer, paraneoplastic syndromes, parathyroid cancer, parotid gland cancer, pelvic tumor, penis cancer, periampullary cancer, pericardial effusion, peripheral nerve sheath tumor, peripheral T-cell lymphoma, peritoneal cancer, extraovarian serous carcinoma, extraovarian peritoneal serious papillary carcinoma, serous surface carcinoma of the peritoneum, serous surface papillary carcinoma, papillary serous carcinoma of the peritoneum, multiple focal peritoneal papillary carcinoma, primary peritoneal papillary serous adenocarcinoma, peritoneal carcinomatosis, pheochromocytoma, pinealoma, pineoblastoma, plasmacytoma, pleura cancer, pleura metastases, preleukemia, primary central nervous system lymphoma, primitive neuroctodermal tumor, PNET, plolymphocytic leukemia, promyelocytic leukemia, prophylactic mastectomy, prostate cancer, prostatic intraepithelial neoplasia, PIN, PSA, pseudomyxoma peritonei, rectal cancer, recurrent colon cancer, recurrent colorectal cancer, recurrent lung cancer, recurrent melanoma, recurrent ovarian cancer, recurrent prostate cancer, recurrent rectal cancer, relapsed lymphoma, renal cell carcinoma, renal pelvis cancer, retinoblastoma, rhabdomyosarcoma, Richters syndrome, rising PSA as an indication of recurrent prostate cancer, salivary gland cancer, sarcoma of bone, sarcomatoid carcinoma; sebaceous carcinoma, sezary syndrome, sinus, cavernous, sinus cancer, skin cancer, skin metastases, small cell bladder cancer, small cell lung cancer, small cleaved cell lymphoma, small intestine cancer, soft tissue lymphoma, soft tissue sarcoma, synovial sarcoma, spinal cord cancer, spindle cell thyroid cancer, squamous cell cancer, non-skin, squamous cell lung cancer, squamous cell skin cancer, stem cell transplantation, stomach cancer, superficial bladder cancer, sweat glands cancer, T-cell leukemia, T-cell lymphoma, cutaneous, testicular cancer, testis cancer, thalamu, thalamic, brain tumor, thymoma, thymus gland cancer, thyroid cancer, thyroid lymphoma, tongue cancer, tongue base cancer, transitional cell cancer of renal pelvis, transitional cell cancer of the ureter, unknown primary cancer, ureter cancer, urethra cancer, uterine cancer, uterine sarcoma, vagina cancer, vocal cord cancer, vulva cancer, Waldenstrom's macroglobulinemia, Warthin's tumor, Wilms' tumor, Zollinger-Ellis syndrome ](CANCELLED)
IC 009. US 021 023 026 036 038. G & S: [ Information processing devices, namely, computer keyboards, mouse, monitors, readers, data processing equipment, compact disc players, optical character readers, computer memories, printers for use with computers, processors; computer programs and software for stockage, management, and analysis of biological information ]

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:9
U.S. Codes:021,023,026,036,038
Type CodeType
GS0051Biological reagents for diagnoses and for identification of biological systems [ ; pharmaceutical products, namely, preparations, chemical preparations and chemico-pharmaceutical preparations for treating illnesses, namely, genetic and infectious illnesses namely, acute leukemia, acute lymphoblastic leukemia, acute myelogenous leukemia, AML, acute monocytic leukemia, AML, acute promyelocytic leukemia, APL, adenocarcinoma, adenocarcinoma lung cancer, adenocystic carcinoma, adenoid cystic breast cancer, adenoid cystic arcinoma, adrenal gland cancer, advanced breast cancer, aggressive breast cancer, ameloblastoma, anal, anus cancer; angiosarcoma, appendix cancer, appendiceal cancer, astrocytoma, arrett's esophagus, bartholin gland cancer, basal cell carcinoma, basal cell skin cancer, B-cell lymphoma, bilateral breast cancer, bile duct cancer, bladder cancer, bladder metastases, bone cancer, bone marrow transplantation, Bowen's disease, bone metastases, borderline ovarian cancer, brain metastases, brain tumor, brainstem glioma, breast cancer, breast reconstruction, bronchial cancer, bronchioalveolar lung cancer, buttock cancer, cancer of unknown primary site, CUPS, cancer prevention, carcinoma of unknown primary, carcinoid, carcinoid syndrome, carcinoid tumor, carcinosarcoma, cavernous sinus cancer, cecum cancer, central nervous system lymphoma, centrocytic lymphoma, cerebral astrocytoma, cervix cancer, cervical cancer, chest tumors, mediastinum tumors, chiasmal glioma, childhood cancers, chondroma, intracranial, chordoma, chondrosarcoma, chorioadenoma destruens, choroids plexus carcinoma, choroidal melanoma, chronic leukemia, chronic lymphocytic leukemia, CLL, chronic myelogenous leukemia, CML, clear cell ovarian cancer, clear cell sarcoma, CNS lymphoma, colon cancer, adenocarcinoma of the colon, adenomatous polyps, polyps, colorectal cancer, craniopharyngioma, cutaneous T-cell lymphoma, DCIS - ductal carcinoma in situ, dermatofibrosarcoma protuberans, desmoidtumor, desmoplastic tumor, diffuse lymphoma, diffuse, large-cell lymphoma, ductal carcinoma in situ, DCIS, duodenalcancer dysgerminoma, early stage prostate cancer, endocrine cancer, endometrial cancer, endometrial stromal sarcoma, ependymoma, esophagus cancer, esophageal cancer, esophagus cancer of the gastroesophageal junction, esthesioneuroblastoma, Ewing's sarcoma, extensive stage small cell lung cancer, extrahepatic bile duct cancer, extraskeletal chondrosarcoma, extraskeletal Ewing's sarcoma, extraskeletal osteosarcoma, eye metastases, eye cancer, fallopian tube cancer, fibrosarcoma, fibrous histiocytoma, follicular lymphoma, follicular, small-cleaved cell lymphoma, gallbladder cancer, gastric cancer, gastrinoma, gastro-esophageal, GE junction, cancer, gastrointestinal lymphoma, GE junction esophageal cancer, germ cell tumor, gestational trophoblastic disease, giant cell bone tumor, glioblastoma, glioma, gliomatosis, granular lymphocytic lymphoma, granulocytic leukemia, granulosa cell ovarian cancer, hairy cell leukemia, head and neck cancer, hemangioendothelioma, hemangiopericytoma, hepatocelluar carcinoma, high-grade lymphoma, high-risk breast cancer, histiocytoma, malignant, Hodgkin's disease, Hodgkin's disease in pregnancy, hormone-refractory prostate cancer, in situ breast cancer, insulinoma, intermediate-grade lymphoma, intraocular melanoma, invasive lobular breast cancer, islet cell pancreatic cancer, Kaposi's sarcoma, kidney cancer, krukenberg tumor, large-cell lung cancer, large-cell lymphoma, large-cell, diffuse lymphoma, larynx cancer, laryngeal cancer, leiomyosarcoma, lentigo maligna, leukemia, linitis plastica, limited stage small cell lung cancer, lip cancer, liposarcoma, liver cancer, recurrent liver cancer, undifferentiated liver cancer, lobular carcinoma in situ, LCIS, lobular hyperplasia low-grade lymphoma, lung cancer, non-small cell lung cancer, epidermoid carcinoma, large cell carcinoma, squamous cell carcinoma, spindal cell variant, pancoast tumors, superior sSulcus tumors, undifferentiated carcinoma, lung metastases, lymph node excision, lymphangitic metastasis, lymph node metastases, lymphoblastic leukemia, lymphoblastic lymphoma, lymphocytic lymphoma, lymphoma, non-Hodgkin's lymphoma, malignant ascites, malignant hemangiopericytoma, malignant fibrous histiocytoma, malignant peripheral nerve sheath tumor, malignant pleural effusion, malignant schwannoma, MALT lymphoma, mantle cell lymphoma, medlastinal tumor, medulloblastoma, melanoma, meningeal cancer, meningeal metastases, meningioma, merkel cell carcinoma, merkel cell skin cancer, mesothelioma, mesenchymal chondrosarcoma, metastatic melanoma, mixed mullerian tumor, mucinous carcinoma, multiple myeloma, muscle-invasive bladder tumor, mycosis fungoides, myelodysplasia, myelodysplastic syndrome, myeloma, Bence-Jones, myeloproliferative disorder, nail/nail bed cancer, nasal cavity cancer, nasopharynx cancer, neck, radical dissection, neoplastic meningitis, nerve sheath tumors, neuroblastoma, neuroendocrine tumor, adenosquamous carcinoma, adenocarcinoma, ocular melanoma, olfactory cancer, oligodendroglioma, optic glioma, oral cancer, orbital lumphoma, orophaiynx cancer, osteogenic sarcoma, osteosarcoma, ovarian cancer, Pagets disease of the breast, pancreatic cancer, recurrent pancreatic cancer, borderline pancreatic tumors, mucinous cystic tumor with dysplasia, intraductal papillary mucinous tumor with dysplasia, pseudopapillary solid tumor, islet cell tumors, gastrinoma, paraganglioma, paranasal sinus cancer, paraneoplastic syndromes, parathyroid cancer, parotid gland cancer, pelvic tumor, penis cancer, periampullary cancer, pericardial effusion, peripheral nerve sheath tumor, peripheral T-cell lymphoma, peritoneal cancer, extraovarian serous carcinoma, extraovarian peritoneal serious papillary carcinoma, serous surface carcinoma of the peritoneum, serous surface papillary carcinoma, papillary serous carcinoma of the peritoneum, multiple focal peritoneal papillary carcinoma, primary peritoneal papillary serous adenocarcinoma, peritoneal carcinomatosis, pheochromocytoma, pinealoma, pineoblastoma, plasmacytoma, pleura cancer, pleura metastases, preleukemia, primary central nervous system lymphoma, primitive neuroctodermal tumor, PNET, plolymphocytic leukemia, promyelocytic leukemia, prophylactic mastectomy, prostate cancer, prostatic intraepithelial neoplasia, PIN, PSA, pseudomyxoma peritonei, rectal cancer, recurrent colon cancer, recurrent colorectal cancer, recurrent lung cancer, recurrent melanoma, recurrent ovarian cancer, recurrent prostate cancer, recurrent rectal cancer, relapsed lymphoma, renal cell carcinoma, renal pelvis cancer, retinoblastoma, rhabdomyosarcoma, Richters syndrome, rising PSA as an indication of recurrent prostate cancer, salivary gland cancer, sarcoma of bone, sarcomatoid carcinoma; sebaceous carcinoma, sezary syndrome, sinus, cavernous, sinus cancer, skin cancer, skin metastases, small cell bladder cancer, small cell lung cancer, small cleaved cell lymphoma, small intestine cancer, soft tissue lymphoma, soft tissue sarcoma, synovial sarcoma, spinal cord cancer, spindle cell thyroid cancer, squamous cell cancer, non-skin, squamous cell lung cancer, squamous cell skin cancer, stem cell transplantation, stomach cancer, superficial bladder cancer, sweat glands cancer, T-cell leukemia, T-cell lymphoma, cutaneous, testicular cancer, testis cancer, thalamu, thalamic, brain tumor, thymoma, thymus gland cancer, thyroid cancer, thyroid lymphoma, tongue cancer, tongue base cancer, transitional cell cancer of renal pelvis, transitional cell cancer of the ureter, unknown primary cancer, ureter cancer, urethra cancer, uterine cancer, uterine sarcoma, vagina cancer, vocal cord cancer, vulva cancer, Waldenstrom's macroglobulinemia, Warthin's tumor, Wilms' tumor, Zollinger-Ellis syndrome ]

Trademark Filing History

DescriptionDateProceeding Number
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP2020-09-24
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)2015-12-1559136
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 82015-12-1559136
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED2015-12-1559136
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED2015-12-15
CASE ASSIGNED TO POST REGISTRATION PARALEGAL2015-12-1559136
TEAS SECTION 8 & 9 RECEIVED2015-10-19
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP2015-10-07
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.2011-07-1464591
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED2011-07-14
CASE ASSIGNED TO POST REGISTRATION PARALEGAL2011-07-1464591
TEAS SECTION 8 & 15 RECEIVED2011-06-02
REGISTERED-PRINCIPAL REGISTER2005-06-07
PUBLISHED FOR OPPOSITION2005-03-15
NOTICE OF PUBLICATION2005-02-23
LAW OFFICE PUBLICATION REVIEW COMPLETED2004-10-2171373
ASSIGNED TO LIE2004-10-1971373
APPROVED FOR PUB - PRINCIPAL REGISTER2004-10-12
AMENDMENT FROM APPLICANT ENTERED2004-10-0767215
PAPER RECEIVED2004-09-22
CORRESPONDENCE RECEIVED IN LAW OFFICE2004-09-2267215
NON-FINAL ACTION MAILED2004-06-04
Sec. 1(B) CLAIM DELETED2004-04-2667215
PAPER RECEIVED2004-04-26
CORRESPONDENCE RECEIVED IN LAW OFFICE2004-04-26
NON-FINAL ACTION MAILED2003-10-23
CASE FILE IN TICRS2003-09-13
LETTER OF SUSPENSION MAILED2003-02-21
PAPER RECEIVED2002-12-13
CORRESPONDENCE RECEIVED IN LAW OFFICE2002-12-13
NON-FINAL ACTION MAILED2002-06-19
UNRESPONSIVE/DUPLICATE PAPER RECEIVED2002-06-17
ASSIGNED TO EXAMINER2002-06-1472146
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED2002-03-15
PAPER RECEIVED2002-03-15
CORRESPONDENCE RECEIVED IN LAW OFFICE2002-03-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed